Tagitanlimab (HBM-9167, KL-A167) is a humanized monoclonal antibody targeting PD-L1 that selectively blocks PD-L1-PD-1 interactions. It can be used to study recurrent or metastatic nasopharyngeal carcinoma (NPC).
Purity:
95.00%
CAS Number:
[2417649-97-7]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted